Published on 24 Jul 20232 new Independent Board Members: Manos Perros & Marco Taglietti"We are thrilled to welcome Dr Manos Perros as our new Chairman of the Board and Dr Marco Taglietti as…
Published on 13 Feb 2023Appointment of Martin Everett as Chief Scientific OfficerCommenting on the appointment, AUROBAC THERAPEUTICS CEO Florence Séjourné: “I am delighted that Martin is joining us. His incredibly strong…
Published on 04 Oct 2022Appointment of Florence Séjourné as Chief Executive Officer“Florence’s is an experienced biotech leader with outstanding strategic and operational acumen. The Board has great confidence in her to…
Published on 06 Jul 2022Boehringer Ingelheim, Evotec and bioMérieux launch AUROBAC THERAPEUTICSBoehringer Ingelheim, Evotec and bioMérieux launch AUROBAC THERAPEUTICS, a joint venture to fight AntiMicrobial Resistance.